Search research articles
Contact Us
Filters
Showing results (1-10 of 28) with videos related to
Page
of 3
Sort By:
Der Radiologe
|
January 18, 2022
[Science and reality]
S Delorme, J Hillengass
Der Radiologe
|
March 24, 2012
[Multiple myeloma: current recommendations for imaging]
J Hillengass, S Delorme
Current Pharmaceutical Biotechnology
|
December 16, 2006
Thalidomide in multiple myeloma
T M Moehler, J Hillengass, A Glasmacher, et al.
Current Pharmaceutical Design
|
April 14, 2004
Antiangiogenic therapy in hematologic malignancies
T M Moehler, J Hillengass, H Goldschmidt, et al.
International Journal of Hematology
|
October 11, 2008
Clinical evidence for immunomodulation induced by high-dose melphalan and autologous blood stem cell transplantation as cause for complete clinical remission of multiple myeloma-associated cryoglobulin-vasculitis
J Hillengass, A D Ho, H Goldschmidt, et al.
Oncoimmunology
|
October 25, 2019
Alternative metrics for assessing clinical benefit with immunotherapy in oncology
E Chan, C Quinn, I Hirji, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 31, 2016
Treatment response evaluation with <sup>18</sup>F-FDG PET/CT and <sup>18</sup>F-NaF PET/CT in multiple myeloma patients undergoing high-dose chemotherapy and autologous stem cell transplantation
Christos Sachpekidis, J Hillengass, H Goldschmidt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 14, 2001
High plasma basic fibroblast growth factor concentration is associated with response to thalidomide in progressive multiple myeloma
K Neben, T Moehler, G Egerer, et al.
Der Radiologe
|
September 15, 2017
[Focal lesions in whole-body MRI in multiple myeloma : Quantification of tumor mass and correlation with disease-related parameters and prognosis]
S C Brandelik, J Krzykalla, T Hielscher, et al.
Transfusion Medicine (Oxford, England)
|
October 12, 2016
Performance assessment and benchmarking of autologous peripheral blood stem cell collection with two different apheresis devices
P Wuchter, M Hundemer, A Schmitt, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 28) with videos related to
Sort By:
Page
of 3
Der Radiologe
|
January 18, 2022
[Science and reality]
S Delorme, J Hillengass
Der Radiologe
|
March 24, 2012
[Multiple myeloma: current recommendations for imaging]
J Hillengass, S Delorme
Current Pharmaceutical Biotechnology
|
December 16, 2006
Thalidomide in multiple myeloma
T M Moehler, J Hillengass, A Glasmacher, et al.
Current Pharmaceutical Design
|
April 14, 2004
Antiangiogenic therapy in hematologic malignancies
T M Moehler, J Hillengass, H Goldschmidt, et al.
International Journal of Hematology
|
October 11, 2008
Clinical evidence for immunomodulation induced by high-dose melphalan and autologous blood stem cell transplantation as cause for complete clinical remission of multiple myeloma-associated cryoglobulin-vasculitis
J Hillengass, A D Ho, H Goldschmidt, et al.
Oncoimmunology
|
October 25, 2019
Alternative metrics for assessing clinical benefit with immunotherapy in oncology
E Chan, C Quinn, I Hirji, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 31, 2016
Treatment response evaluation with <sup>18</sup>F-FDG PET/CT and <sup>18</sup>F-NaF PET/CT in multiple myeloma patients undergoing high-dose chemotherapy and autologous stem cell transplantation
Christos Sachpekidis, J Hillengass, H Goldschmidt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 14, 2001
High plasma basic fibroblast growth factor concentration is associated with response to thalidomide in progressive multiple myeloma
K Neben, T Moehler, G Egerer, et al.
Der Radiologe
|
September 15, 2017
[Focal lesions in whole-body MRI in multiple myeloma : Quantification of tumor mass and correlation with disease-related parameters and prognosis]
S C Brandelik, J Krzykalla, T Hielscher, et al.
Transfusion Medicine (Oxford, England)
|
October 12, 2016
Performance assessment and benchmarking of autologous peripheral blood stem cell collection with two different apheresis devices
P Wuchter, M Hundemer, A Schmitt, et al.
Page
of 3